Concepedia

Jennifer A. Woyach

JA

154

Publications

15.3K

Citations

57

H-Index

2008

Active since

Affiliations

The Ohio State University(Current)

The University of Texas MD Anderson Cancer Center

Dana-Farber Cancer Institute

Vita-Salute San Raffaele University

IRCCS Ospedale San Raffaele

Jennifer A. Woyach is an author at The Ohio State University specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2008–2025

154

Publications

154

Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib

Jennifer A. Woyach, Richard R. Furman, Ta-Ming Liu et al. · New England Journal of Medicine · 2014 · 1.2K citations · Full text

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema et al. · New England Journal of Medicine · 2018 · 927 citations · Full text

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia

John C. Byrd, Bonnie K. Harrington, Susan O’Brien et al. · New England Journal of Medicine · 2015 · 878 citations · Full text

Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes

Jason A. Dubovsky, Kyle A. Beckwith, Gayathri Natarajan et al. · Blood · 2013 · 783 citations · Full text

Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzumab for treatment-naive chronic lymphocytic leukaemia (ELEVATE-TN): a randomised, controlled, phase 3 trial

Jeff P. Sharman, Miklós Egyed, Wojciech Jurczak et al. · The Lancet · 2020 · 583 citations · Full text

, , +8

Rows per page

1–5 of 154